Research progress on small molecule inhibitors of coronaviruses / 药学实践杂志
Journal of Pharmaceutical Practice
;
(6): 385-397, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-825613
ABSTRACT
Coronavirus infection seriously threatens human health. There is no specific medication or vaccine so far. In recent years, domestic and foreign researchers have developed a variety of small-molecule inhibitors against the ligand S protein, RdRp, PLpro and 3CLpro of three highly pathogenic coronavirus, SARS-CoV,MERS-CoV,SARS-CoV-2. This article reviews the characteristics of these coronaviruses, action targets, small molecule inhibitors, and structure-activity relationships.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Pharmaceutical Practice
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS